Topchoice Medical Co., Inc. (SHA:600763)
China
· Delayed Price · Currency is CNY 43.26
-0.23 (-0.53%)
Apr 29, 2026, 3:00 PM CST
Topchoice Medical Co. Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 591.34 | 588.29 | 501.43 | 500.44 | 548.27 | 702.81 | Upgrade
|
| Depreciation & Amortization | 194.04 | 194.04 | 202.61 | 189.35 | 173.31 | 153.8 | Upgrade
|
| Other Amortization | 69.38 | 69.38 | 65.25 | 55.25 | 46.1 | 35 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.27 | 0.27 | -0.14 | - | 0.05 | 0.02 | Upgrade
|
| Asset Writedown & Restructuring Costs | -0.54 | -0.54 | 0.86 | 0.42 | 0.51 | 0.21 | Upgrade
|
| Loss (Gain) From Sale of Investments | -46.43 | -46.43 | -47.84 | -60.19 | -38.3 | -56.13 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 3.17 | 1.75 | 1.67 | 1.29 | Upgrade
|
| Other Operating Activities | 58.17 | 47.83 | 114.15 | 131.85 | 117.71 | 109.25 | Upgrade
|
| Change in Accounts Receivable | -42.73 | -42.73 | -28.94 | -37.77 | -45.07 | -46.88 | Upgrade
|
| Change in Inventory | 10.22 | 10.22 | -3.74 | -1.9 | -2.55 | -2.68 | Upgrade
|
| Change in Accounts Payable | -3.78 | -3.78 | -37.3 | 71.22 | -122.12 | 36.97 | Upgrade
|
| Change in Other Net Operating Assets | -1.64 | -1.64 | -1.64 | -1.64 | -1.64 | -1.64 | Upgrade
|
| Operating Cash Flow | 824.1 | 810.72 | 763.41 | 841.02 | 670.05 | 939.41 | Upgrade
|
| Operating Cash Flow Growth | 5.53% | 6.20% | -9.23% | 25.52% | -28.67% | 32.59% | Upgrade
|
| Capital Expenditures | -236.15 | -246.2 | -332.11 | -508.9 | -421.53 | -367.32 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.15 | 2.15 | 2.02 | 0.01 | 0.62 | 0.02 | Upgrade
|
| Cash Acquisitions | -15 | -15 | -27.73 | - | - | - | Upgrade
|
| Divestitures | - | - | - | -0.03 | - | 131.95 | Upgrade
|
| Investment in Securities | 3.23 | 5.97 | -7.04 | -504.25 | -60.45 | -234.42 | Upgrade
|
| Other Investing Activities | -49.86 | -26.16 | -94.21 | -14.47 | -15.99 | -14 | Upgrade
|
| Investing Cash Flow | -295.62 | -279.24 | -324.97 | -887.63 | -497.35 | -483.77 | Upgrade
|
| Long-Term Debt Issued | - | 50 | 80 | 280 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -100 | -252.43 | -193.57 | -251.18 | -241.76 | Upgrade
|
| Net Debt Issued (Repaid) | 111 | -50 | -172.43 | 86.43 | -251.18 | -241.76 | Upgrade
|
| Repurchase of Common Stock | - | - | -30.1 | -1 | -99.99 | - | Upgrade
|
| Common Dividends Paid | -209.11 | -208.89 | -149.89 | -11.24 | -6.69 | -12.87 | Upgrade
|
| Other Financing Activities | -235.12 | -196.14 | -60.26 | -63.04 | -28.33 | -31.3 | Upgrade
|
| Financing Cash Flow | -333.23 | -455.02 | -412.69 | 11.15 | -386.19 | -285.93 | Upgrade
|
| Net Cash Flow | 195.25 | 76.46 | 25.75 | -35.46 | -213.5 | 169.71 | Upgrade
|
| Free Cash Flow | 587.96 | 564.52 | 431.3 | 332.13 | 248.52 | 572.09 | Upgrade
|
| Free Cash Flow Growth | 14.15% | 30.89% | 29.86% | 33.64% | -56.56% | 6.33% | Upgrade
|
| Free Cash Flow Margin | 20.11% | 19.38% | 15.01% | 11.67% | 9.14% | 20.57% | Upgrade
|
| Free Cash Flow Per Share | 1.31 | 1.26 | 0.96 | 0.74 | 0.55 | 1.27 | Upgrade
|
| Cash Income Tax Paid | 154.5 | 153.52 | 162.07 | 142.52 | 227.01 | 105.67 | Upgrade
|
| Levered Free Cash Flow | 398.47 | 412.38 | 330.35 | 331.44 | -199.6 | 365.3 | Upgrade
|
| Unlevered Free Cash Flow | 398.47 | 412.38 | 358.75 | 365.82 | -168.32 | 383.37 | Upgrade
|
| Change in Working Capital | -42.12 | -42.12 | -76.06 | 22.15 | -179.26 | -6.83 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.